Hematopoietic stem cell transplantation (HSCT) is performed for complete healing of hematologic disorders and as a supportive therapy after high-dose chemotherapy against malignant diseases.
造血干细胞移植(HSCT)常被用来治疗血液系统疾病和作为血液系统恶性疾病高剂量化疗后的支持治疗。
Results: the bone marrow cells from healthy controls and patients with benign hematologic diseases had no EGFR expression and so did the bone marrow cells from malignant hematologic diseases.
结果：在正常人及骨髓良性增生性疾病患者的骨髓细胞中未见EGFR表达，在恶性血液病患者的骨髓细胞中也未见EGFR表达。
应用推荐